Equities
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)116.50
  • Today's Change1.50 / 1.30%
  • Shares traded83.08k
  • 1 Year change+25.67%
  • Beta0.5937
Data delayed at least 15 minutes, as of Sep 19 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,5441,4881,485
Total Receivables, Net134149149
Total Inventory181143103
Prepaid expenses1.711.870
Other current assets, total131516
Total current assets1,8741,7971,752
Property, plant & equipment, net213158154
Goodwill, net165172149
Intangibles, net464648
Long term investments282622
Note receivable - long term------
Other long term assets------
Total assets2,3332,2142,128
LIABILITIES
Accounts payable493242
Accrued expenses867856
Notes payable/short-term debt000
Current portion long-term debt/capital leases8.80118.90
Other current liabilities, total514419
Total current liabilities196165127
Total long term debt0010
Total debt8.801119
Deferred income tax151314
Minority interest0.000.000.00
Other liabilities, total926499
Total liabilities303242251
SHAREHOLDERS EQUITY
Common stock202020
Additional paid-in capital1,1531,1541,154
Retained earnings (accumulated deficit)857798703
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2,0301,9721,877
Total liabilities & shareholders' equity2,3332,2142,128
Total common shares outstanding10110198
Treasury shares - common primary issue0--0
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.